Series B - WuXi Diagnostics

Series B - WuXi Diagnostics

Investment Firm

Overview

WuXi Diagnostics is the first enabling platform company in China to practice integrated diagnosis.

Announced Date

Feb 23, 2021

Closed on Date

Feb 23, 2021

Funding Type

Series B

Highlights

Location

Asia

Social

Investor Lead

N/A

Participant Investors

3

Investor Name
Participant InvestorSunland Capital
Participant InvestorYF Capital
Participant InvestorThermo Fisher Scientific

Round Details and Background

WuXi Diagnostics raised $150000000 on 2021-02-23 in Series B

WuXi Diagnostics is the first enabling platform company in China to practice integrated diagnosis.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 23, 2021
Series B - WuXi Diagnostics
6-150.0M
Jan 01, 2019
Series A - WuXi Diagnostics
1-undefined

Recent Activity

There is no recent news or activity for this profile.